# TRANSDERMAL FORMULATION OF NICARDIPINE HYDROCHLORIDE

## Abstract
A transdermal formulation of nicardipine hydrochloride which comprises a a transdermal formulation base com pounded with b nicardipine hydrochloride dissolved or suspended in a liquid containing a urea and at least one compound selected from propylene glycol, monohydric alcohols having 2 to 4 carbon atoms, lactic acid, thioglycol, middle chain fatty acid glycerides and sorbitan middle chain fatty acid esters. Such formulations give improved percu taneous absorption of the nicardipine hydrochloride. Inclusion in the formulation of crystallizing inhibitor for nicardipine hydrochloride can improve the stability of the formulation.